Advertisement
Advertisement

LAB

LAB logo

Standard BioTools Inc

2.04
USD
-0.17
-7.69%
Dec 18, 14:50 UTC -5
Open

Standard BioTools Inc Profile

About

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Michael Egholm

Headquarters

2 Tower Place, Ste 2000
South San Francisco, CA 94080, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

267

Employees

539

Standard BioTools Inc Statistics

Valuation Measures

Market Capitalization2

759.41M

Enterprise Value

603.98M

Enterprise Value/EBITDA(ttm)

-3.97

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.56

Price to Book(mrq)

1.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

48.12%

Operating Margin(ttm)

-61.97%

Profit Margin(ttm)

-106.15%

Return on Equity(ttm)

-27.05%

Return on Invested Capital(ttm)

-31.85%

Return on Assets(ttm)

-15.52%

Income Statement

Revenue(ttm)

155.90M

Revenue Per Share(ttm)

0.42

Gross Profit(ttm)

75.77M

EBITDA(ttm)3

-152.20M

Net Income Available to Common(ttm)

-170.60M

Diluted EPS(ttm)

-0.71

Share Statistics

Beta (5Y Monthly)

1.61

52-Week Change

-19.37%

S&P 500 52-Week Change

26.81%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

372.26M

Dividend Yield

0.00%

Float4

174.59M

% Held by Insiders

53.10%

% Held by Institutions

53.74%

Balance Sheet

Total Cash(mrq)

366.33M

Total Cash Per Share(mrq)

0.98

Total Debt(mrq)

55.21M

Total Debt/Equity(mrq)

11.28%

Current Ratio(mrq)

3.76%

Quick Ratio(mrq)

3.41%

Book Value Per Share(mrq)

1.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.35

Free Cash Flow(ytd)

-134.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement